Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis

BACKGROUND: Dimethyl fumarate and fingolimod are oral disease modifying treatments (DMTs) that reduce relapse activity and slow disability worsening in relapsing–remitting multiple sclerosis (RRMS). OBJECTIVE: To compare the effectiveness of dimethyl fumarate and fingolimod in a real-world setting,...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Neurol
Huvudupphovsmän: Lorscheider, Johannes, Benkert, Pascal, Lienert, Carmen, Hänni, Peter, Derfuss, Tobias, Kuhle, Jens, Kappos, Ludwig, Yaldizli, Özgür
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer Berlin Heidelberg 2020
Ämnen:
Original Communication
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7914245/
https://ncbi.nlm.nih.gov/pubmed/32974794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-020-10226-6
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk